Pemetrexed and Gemcitabine for Chemotherapy Refractory Colorectal Cancer—Results of a Phase II and Translational Research Study

Karen-Lise Garm Spindler; Niels Pallisgaard; Rikke Fredslund Andersen; John Ploen; Anders Jakobsen

doi:10.4236/jct.2013.46a2006

Pemetrexed and Gemcitabine for Chemotherapy Refractory Colorectal Cancer—Results of a Phase II and Translational Research Study

Journal of Cancer Therapy ◽

10.4236/jct.2013.46a2006 ◽

2013 ◽

Vol 04 (06) ◽

pp. 44-50 ◽

Cited By ~ 4

Author(s):

Karen-Lise Garm Spindler ◽

Niels Pallisgaard ◽

Rikke Fredslund Andersen ◽

John Ploen ◽

Anders Jakobsen

Keyword(s):

Colorectal Cancer ◽

Translational Research ◽

Phase Ii ◽

Research Study

Download Full-text

Abstract LB-220: Translational research with RG7160 (GA201) leads to a phase II clinical study in combination with FOLFIRI in 2ndline metastatic colorectal cancer (mCRC)

10.1158/1538-7445.am2012-lb-220 ◽

2012 ◽

Author(s):

Andrés Cervantes ◽

Ben Markman ◽

Salvatore Siena ◽

Carles Pericay ◽

Giuseppe Aprile ◽

...

Keyword(s):

Colorectal Cancer ◽

Clinical Study ◽

Metastatic Colorectal Cancer ◽

Translational Research ◽

Phase Ii ◽

Phase Ii Clinical Study

Download Full-text

Prognostic Significance of Tumour-Associated Immune Response Gene Expression, Esr1 and Clinicopathologic Parameters in Stage Ii/Iii Colorectal Cancer: a Translational Research Study of the Hellenic Cooperative Oncology Group (Hecog)

Annals of Oncology ◽

10.1093/annonc/mdu333.68 ◽

2014 ◽

Vol 25 ◽

pp. iv194

Author(s):

G. Pentheroudakis ◽

V. Kotoula ◽

G. Raptou ◽

V. Karavasilis ◽

G. Gourioti ◽

...

Keyword(s):

Gene Expression ◽

Colorectal Cancer ◽

Immune Response ◽

Translational Research ◽

Research Study ◽

Prognostic Significance ◽

Immune Response Gene ◽

Oncology Group ◽

Response Gene ◽

Clinicopathologic Parameters

Download Full-text

A Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab with or Without Bevacizumab as Frontline Therapy for Metastatic Colorectal Cancer. A Fox Chase Extramural Research Study

Journal of Gastrointestinal Cancer ◽

10.1007/s12029-012-9368-3 ◽

2012 ◽

Vol 43 (4) ◽

pp. 562-569 ◽

Cited By ~ 16

Author(s):

Efrat Dotan ◽

Neal J. Meropol ◽

Barbara Burtness ◽

Crystal S. Denlinger ◽

James Lee ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Research Study ◽

Phase Ii Study ◽

Frontline Therapy ◽

Extramural Research

Download Full-text

Application of RT-PCR to clinical diagnosis of micrometastasis of colorectal cancer: A translational research study

International Journal of Oncology ◽

10.3892/ijo.25.3.597 ◽

2004 ◽

Cited By ~ 2

Author(s):

Osamu Takayama ◽

Hirofumi Yamamoto ◽

Kimimasa Ikeda ◽

Hideyuki Ishida ◽

Takeshi Kato ◽

...

Keyword(s):

Colorectal Cancer ◽

Translational Research ◽

Clinical Diagnosis ◽

Research Study ◽

Rt Pcr

Download Full-text

Faculty Opinions recommendation of A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697918.793457734 ◽

2012 ◽

Author(s):

Hans-Joachim Schmoll

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

Dose Dense ◽

First Line Treatment

Download Full-text

Faculty Opinions recommendation of FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717997102.793478384 ◽

2013 ◽

Author(s):

Sabine Tejpar ◽

Loredana Vecchione

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Line Treatment ◽

Wild Type ◽

First Line ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

172PD Final analysis: Phase II trial of irinotecan/S-1/cetuximab (IRIS/Cet) as second line treatment in patients with KRAS exon2 wild type metastatic colorectal cancer: HGCSG0902. Comparison of administration interval in cetuximab treatment

Annals of Oncology ◽

10.1016/s0923-7534(21)00330-6 ◽

2016 ◽

Vol 27 ◽

pp. ix54

Author(s):

T. Ando ◽

S. Yuki ◽

H. Nakatsumi ◽

T. Muranaka ◽

A. Hosokawa ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Final Analysis ◽

Line Treatment ◽

Second Line ◽

Wild Type ◽

Analysis Phase ◽

Administration Interval

Download Full-text

Startup and implementation costs of a colorectal cancer screening tailored navigation research study

Evaluation and Program Planning ◽

10.1016/j.evalprogplan.2021.101907 ◽

2021 ◽

Vol 85 ◽

pp. 101907

Author(s):

Julie Bucho-Gonzalez ◽

Patricia M. Herman ◽

Linda Larkey ◽

Usha Menon ◽

Laura Szalacha

Keyword(s):

Colorectal Cancer ◽

Cancer Screening ◽

Colorectal Cancer Screening ◽

Research Study ◽

Implementation Costs

Download Full-text

A prospective phase II study of raltitrexed combined with S‐1 as salvage treatment for patients with refractory metastatic colorectal cancer

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.13511 ◽

2021 ◽

Author(s):

Mingzhu Huang ◽

Yue Yang ◽

Xiaodong Zhu ◽

Zhiyu Chen ◽

Wen Zhang ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Salvage Treatment ◽

Prospective Phase

Download Full-text

Multicenter phase II study of combination therapy with cetuximab and S-1 in patients with KRAS exon 2 wild-type unresectable colorectal cancer previously treated with irinotecan, oxaliplatin, and fluoropyrimidines (KSCC 0901 study)

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-016-3109-4 ◽

2016 ◽

Vol 78 (3) ◽

pp. 585-593 ◽

Cited By ~ 3

Author(s):

Takao Takahashi ◽

◽

Yasunori Emi ◽

Eiji Oki ◽

Kazuma Kobayashi ◽

...

Keyword(s):

Colorectal Cancer ◽

Combination Therapy ◽

Phase Ii ◽

Phase Ii Study ◽

Wild Type ◽

Exon 2 ◽

Multicenter Phase ◽

Previously Treated ◽

Kras Exon

Download Full-text